Bifogade filer
Kurs & Likviditet
Kalender
2024-11-12 | Kvartalsrapport 2024-Q3 |
2024-08-13 | Kvartalsrapport 2024-Q2 |
2024-05-15 | Ordinarie utdelning MOB 0.00 SEK |
2024-05-14 | Årsstämma 2024 |
2024-05-07 | Kvartalsrapport 2024-Q1 |
2024-02-13 | Bokslutskommuniké 2023 |
2023-11-07 | Kvartalsrapport 2023-Q3 |
2023-10-09 | Extra Bolagsstämma 2023 |
2023-08-03 | Kvartalsrapport 2023-Q2 |
2023-05-24 | Split MOB 10:1 |
2023-05-17 | Ordinarie utdelning MOB 0.00 SEK |
2023-05-16 | Årsstämma 2023 |
2023-05-09 | Kvartalsrapport 2023-Q1 |
2023-02-07 | Bokslutskommuniké 2022 |
2022-11-08 | Kvartalsrapport 2022-Q3 |
2022-08-09 | Kvartalsrapport 2022-Q2 |
2022-05-17 | Ordinarie utdelning MOB 0.00 SEK |
2022-05-16 | Årsstämma 2022 |
2022-05-10 | Kvartalsrapport 2022-Q1 |
2022-05-03 | Extra Bolagsstämma 2022 |
2022-02-08 | Bokslutskommuniké 2021 |
2021-11-09 | Kvartalsrapport 2021-Q3 |
2021-08-10 | Kvartalsrapport 2021-Q2 |
2021-05-11 | Kvartalsrapport 2021-Q1 |
2021-03-31 | Ordinarie utdelning MOB 0.00 SEK |
2021-03-30 | Årsstämma 2021 |
2021-02-09 | Bokslutskommuniké 2020 |
2020-12-01 | Extra Bolagsstämma 2020 |
2020-05-12 | Kvartalsrapport 2020-Q3 |
2020-02-11 | Kvartalsrapport 2020-Q2 |
2019-11-19 | Kvartalsrapport 2020-Q1 |
2019-11-04 | Inlösen MOB 46.5 |
2019-10-31 | Ordinarie utdelning MOB 0.00 SEK |
2019-10-30 | Årsstämma 2020 |
2019-08-29 | Bokslutskommuniké 2019 |
2019-05-16 | Ordinarie utdelning MOB 0.00 SEK |
2019-05-15 | Årsstämma 2019 |
2019-05-14 | Kvartalsrapport 2019-Q1 |
2019-03-15 | Extra Bolagsstämma 2019 |
2019-02-12 | Bokslutskommuniké 2018 |
2018-11-06 | Kvartalsrapport 2018-Q3 |
2018-08-07 | Kvartalsrapport 2018-Q2 |
2018-05-16 | Ordinarie utdelning MOB 0.00 SEK |
2018-05-15 | Årsstämma 2018 |
2018-05-08 | Kvartalsrapport 2018-Q1 |
2018-02-13 | Bokslutskommuniké 2017 |
2017-11-13 | Kvartalsrapport 2017-Q3 |
2017-08-08 | Kvartalsrapport 2017-Q2 |
2017-05-17 | Ordinarie utdelning MOB 0.00 SEK |
2017-05-16 | Årsstämma 2017 |
2017-05-09 | Kvartalsrapport 2017-Q1 |
2017-02-14 | Bokslutskommuniké 2016 |
2016-11-08 | Kvartalsrapport 2016-Q3 |
2016-08-09 | Kvartalsrapport 2016-Q2 |
2016-05-19 | Ordinarie utdelning MOB 0.00 SEK |
2016-05-18 | Årsstämma 2016 |
2016-05-10 | Kvartalsrapport 2016-Q1 |
2016-02-17 | Bokslutskommuniké 2015 |
2015-11-10 | Kvartalsrapport 2015-Q3 |
2015-08-11 | Kvartalsrapport 2015-Q2 |
2015-05-12 | Ordinarie utdelning MOB 0.00 SEK |
2015-05-11 | Årsstämma 2015 |
2015-05-11 | Bokslutskommuniké 2014 |
2015-05-11 | Kvartalsrapport 2015-Q1 |
2015-02-27 | Bokslutskommuniké 2014 |
2014-11-14 | Kvartalsrapport 2014-Q3 |
2014-08-13 | Kvartalsrapport 2014-Q2 |
2014-05-14 | Ordinarie utdelning MOB 0.00 SEK |
2014-05-13 | Årsstämma 2014 |
2014-05-13 | Kvartalsrapport 2014-Q1 |
2014-02-20 | Bokslutskommuniké 2013 |
2013-11-05 | Kvartalsrapport 2013-Q3 |
2013-08-06 | Kvartalsrapport 2013-Q2 |
2013-05-21 | Kvartalsrapport 2013-Q1 |
2013-05-21 | Analytiker möte 2013 |
2013-04-24 | Ordinarie utdelning MOB 0.00 SEK |
2013-04-23 | Årsstämma 2013 |
2013-03-13 | 15-7 2013 |
2013-02-05 | Bokslutskommuniké 2012 |
2012-11-19 | Extra Bolagsstämma 2012 |
2012-10-25 | Kvartalsrapport 2012-Q3 |
2012-09-20 | Kapitalmarknadsdag 2012 |
2012-08-28 | Kvartalsrapport 2012-Q2 |
2012-06-11 | 15-7 2012 |
2012-04-24 | Ordinarie utdelning MOB 0.00 SEK |
2012-04-23 | Årsstämma 2012 |
2012-04-23 | Kvartalsrapport 2012-Q1 |
2012-02-09 | Bokslutskommuniké 2011 |
2011-11-29 | 15-7 2011 |
2011-10-28 | Kvartalsrapport 2011-Q3 |
2011-08-12 | Kvartalsrapport 2011-Q2 |
2011-04-18 | Kvartalsrapport 2011-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
STOCKHOLM, June 27th, 2019 - The Board of Directors of Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has resolved, pursuant to the authorization granted by the Annual General Meeting held on May 15th, 2019, to transfer not more than 45,000 of the Company's ordinary shares on Nasdaq Stockholm. The purpose of the transfer is to cover certain costs, mainly social security costs, that may arise in relation to implemented incentive programs.
As previously disclosed, the Company has implemented share-based incentive programs for senior executives and other employees. The Company currently has four outstanding incentive programs, employee stock option plans for 2015, 2016, 2017 and a long-term incentive program for 2018 (LTI 2018) (the "Programs"). The Company's recent divestment of its OTC-business has resulted in a requirement for an acceleration of the vesting period for all Programs, which the Board of Directors has resolved on. Such an acceleration entails that participants, to a certain extent, are allotted shares or employee stock options already during the current year and, thus, social security and other costs will arise. The Board of Directors has therefore resolved, on the basis of the authorization from the Annual General Meeting, to transfer the Company's ordinary shares to cover costs which may arise as a result of this.
Transfer may commence on June 27th, 2019, and shall end no later than July 30th, 2019, and will be administrated by Aktieinvest FK AB, which, based on the trading order given by the Company to Aktieinvest FK AB, will take trading decisions independently of the Company with regard to the timing of the transfers.
Transfers may comprise a maximum of 45,000 ordinary shares on one or several occasions and shall be made on Nasdaq Stockholm in accordance with its Rule Book for Issuers. The transfers will be made at a price per share within the from time to time registered trading interval. Reporting will take place through the stock exchange in accordance with applicable rules.
The total number of shares in Moberg Pharma amounts to 18,364,605, of which 17,703,762 ordinary shares and 660,843 are shares of series B. At the time of this press release the Company holds 226,836 own ordinary shares.
Anna Ljung, CEO, Phone: +46 8 522 307 01 (SE), e-mail: